Gregory G. Freitag's most recent trade in PDS Biotechnology Corporation was a trade of 22,700 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PDS Biotechnology Corporation | Gregory G. Freitag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 22,700 | 22,700 | - | - | Employee Stock Option (Right to Buy) | |
| PDS Biotechnology Corporation | Gregory G. Freitag | Director | Purchase of securities on an exchange or from another person at price $ 1.66 per share. | 28 Feb 2025 | 15,060 | 61,213 (0%) | 0% | 1.7 | 25,000 | Common Stock |
| PDS Biotechnology Corporation | Gregory G. Freitag | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 28 Feb 2025 | 15,060 | 15,060 | - | - | Common Warrant | |
| PDS Biotechnology Corporation | Gregory G. Freitag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 9,000 | 9,000 | - | - | Employee Stock Option (Right to Buy) | |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 11,904 | 0 | - | - | Restricted Stock Units | |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 11,904 | 283,498 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Gregory G. Freitag | Director | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 07 Mar 2024 | 25,000 | 271,594 (0%) | 0% | 9 | 225,000 | Common Stock |
| PDS Biotechnology Corporation | Gregory G. Freitag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 9,000 | 9,000 | - | - | Employee Stock Option (Right to Buy) | |
| Axogen Inc. | Gregory G. Freitag | Director | Sale of securities on an exchange or to another person at price $ 8.74 per share. | 01 Jun 2023 | 29,480 | 290,135 (0%) | 0% | 8.7 | 257,655 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Sale of securities on an exchange or to another person at price $ 8.65 per share. | 01 Jun 2023 | 12,500 | 319,615 (0%) | 0% | 8.7 | 108,125 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 6,459 | 0 | - | - | Restricted Stock Units | |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 6,459 | 296,594 (0%) | 0% | 0 | Common Stock | |
| ZyVersa Therapeutics Inc | Gregory G. Freitag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 132 | 132 | - | - | Stock Options | |
| Axogen Inc. | Gregory G. Freitag | Director | Sale of securities on an exchange or to another person at price $ 9.26 per share. | 23 May 2023 | 4,640 | 332,115 (0%) | 0% | 9.3 | 42,966 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Sale of securities on an exchange or to another person at price $ 9.17 per share. | 23 May 2023 | 2,828 | 336,755 (0%) | 0% | 9.2 | 25,933 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Sale of securities on an exchange or to another person at price $ 12.74 per share. | 14 Nov 2022 | 13,000 | 339,583 (0%) | 0% | 12.7 | 165,620 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Sale of securities on an exchange or to another person at price $ 12.50 per share. | 08 Nov 2022 | 13,000 | 352,583 (0%) | 0% | 12.5 | 162,500 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Sale of securities on an exchange or to another person at price $ 9.70 per share. | 10 Aug 2022 | 8,886 | 365,583 (0%) | 0% | 9.7 | 86,159 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Sale of securities on an exchange or to another person at price $ 10.64 per share. | 04 Aug 2022 | 24,000 | 387,515 (0%) | 0% | 10.6 | 255,360 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Sale of securities on an exchange or to another person at price $ 10.37 per share. | 04 Aug 2022 | 13,046 | 374,469 (0%) | 0% | 10.4 | 135,287 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2022 | 83,000 | 0 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.38 per share. | 25 Jul 2022 | 83,000 | 441,811 (1%) | 0% | 3.4 | 280,540 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.26 per share. | 25 Jul 2022 | 30,296 | 411,515 (1%) | 0% | 9.3 | 280,541 | Common Stock |
| PDS Biotechnology Corporation | Gregory G. Freitag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2022 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Axogen Inc. | Gregory G. Freitag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 11,811 | 11,811 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Gregory G. Freitag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 6,459 | 6,459 | - | - | Restricted Stock Units | |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 3,036 | 0 | - | - | Restricted Stock Units | |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 3,036 | 358,811 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.17 per share. | 17 Jun 2021 | 9,250 | 364,556 (0%) | 0% | 19.2 | 177,323 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jun 2021 | 9,250 | 0 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Gregory G. Freitag | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.92 per share. | 17 Jun 2021 | 8,781 | 355,775 (0%) | 0% | 20.9 | 183,699 | Common Stock |
| PDS Biotechnology Corporation | Gregory G. Freitag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| PDS Biotechnology Corporation | Gregory G. Freitag | Director | Purchase of securities on an exchange or from another person at price $ 8.50 per share. | 15 Jun 2021 | 5,882 | 46,153 (0%) | 0% | 8.5 | 49,997 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2021 | 24,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.67 per share. | 04 Jun 2021 | 24,000 | 355,306 (0%) | 0% | 3.7 | 88,080 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 6,030 | 6,030 | - | - | Stock Option (right to purchase) | |
| Axogen Inc. | Gregory G. Freitag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 3,036 | 3,036 | - | - | Restricted Stock Units | |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.95 per share. | 26 May 2021 | 50,000 | 331,306 (0%) | 0% | 9.0 | 447,500 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2021 | 50,000 | 0 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.67 per share. | 26 May 2021 | 22,954 | 251,306 (0%) | 0% | 3.7 | 84,241 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2021 | 22,954 | 0 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. | 26 May 2021 | 15,000 | 281,306 (0%) | 0% | 5.5 | 81,750 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2021 | 15,000 | 0 | - | - | Stock Option (right to purchase) | |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.09 per share. | 26 May 2021 | 9,000 | 260,306 (0%) | 0% | 5.1 | 45,810 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2021 | 9,000 | 0 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.45 per share. | 26 May 2021 | 6,000 | 266,306 (0%) | 0% | 5.5 | 32,700 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 May 2021 | 6,000 | 0 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Gregory G. Freitag | Director | Sale of securities on an exchange or to another person at price $ 22.06 per share. | 25 Feb 2021 | 24,000 | 228,352 (0%) | 0% | 22.1 | 529,440 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 3,377 | 252,145 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Gregory G. Freitag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 1,784 | 252,897 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Gregory G. Freitag | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.70 per share. | 16 Feb 2021 | 1,032 | 251,113 (0%) | 0% | 18.7 | 19,298 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.70 per share. | 16 Feb 2021 | 545 | 252,352 (0%) | 0% | 18.7 | 10,192 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2020 | 2,300 | 249,261 (0%) | 0% | - | Common Stock | |
| Axogen Inc. | Gregory G. Freitag | Director | Sale of securities on an exchange or to another person at price $ 17.81 per share. | 27 Dec 2020 | 916 | 248,345 (0%) | 0% | 17.8 | 16,314 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2020 | 925 | 245,455 (0%) | 0% | - | Common Stock | |
| Axogen Inc. | Gregory G. Freitag | Director | Sale of securities on an exchange or to another person at price $ 16.42 per share. | 18 Dec 2020 | 379 | 245,076 (0%) | 0% | 16.4 | 6,223 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.67 per share. | 15 Sep 2020 | 13,046 | 244,530 (0%) | 0% | 3.7 | 47,879 | Common Stock |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2020 | 9,000 | 24,000 | - | - | Common Stock | |
| Axogen Inc. | Gregory G. Freitag | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2020 | 4,046 | 22,954 | - | - | Common Stock |